STAT+: Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/847ea623627dc1eb4a530d69c3578cc49d7e0bf6"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about a Lilly access program, a Gilead court victory, and more"></iframe>